Denner Alexander J's Form 4 filing
Ironwood Pharmaceuticals Inc (IRWD) · filed Mar 17, 2026
- Accession no.
- 0001193125-26-111581
- Filed
- Mar 17, 2026
- Trade date
- Mar 13-17, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $20.5M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Denner Alexander JCIK 0001361754 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | Class A Common Stock | AGrant or awardAcquired | +4,451 | $0.00 | $0 | 256,309 | Direct | |
| Mar 17, 2026 | Class A Common Stock | SSaleDisposed | −6,725,000 | $3.05 | −$20,511,250 | 9,194,435 | Indirect | |
| Mar 17, 2026 | Class A Common Stock | SSaleDisposed | −5,800 | $3.31 | −$19,198 | 9,188,635 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
Exhibit 24 - Power of Attorney